The list of Medtronic's (Dublin) acquisitions since its merger with Covidien continues to rapidly expand. This time the company is picking up Lazarus Effect, (Campbell, Calif.), a private company focused on products that facilitate the capture and removal of clots, in an all cash-transaction valued at $100 million. Read More
